Delivery Order SPE2DB20D9127-SPE2DB24FPQJ4
Award Date 4/12/24
Potential Completion Date 5/3/24
Potential Value $37K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is to provide XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, with a potential value of $3,094.80 and a completion date of February 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds numerous contracts and indefinite delivery vehicles (IDVs) with DLA to supply a wide range of pharmaceuticals...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML syringes and has a performance period through May 2, 2024. This award is placed against DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with DLA, valued at up to $4,999,999 through 2025. Under this broader contract vehicle, DMS Pharmaceutical Group...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business, for the supply of XOLAIR 150 MG/ML SYRINGE. The contract is a firm fixed-price delivery order with a potential value of $27,853.20 and a completion date of February 22, 2024. This delivery order is placed against DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, contract 4600082013 under the SPE2DB program, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 MG/ML syringes. The contract is a firm fixed-price delivery order with a ceiling value of $7,737.00 and a period of performance through April 5, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery vehicle (IDV) contract, #4600082013 under the SPE2DB program, with DLA valued at up to $4,999,999 through the end of...
- This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, involves the delivery of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA). The single-award, firm-fixed-price contract has a ceiling value of $10,058.10 and runs through April 17, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, valued up to $4,999,999, that DMS Pharmaceutical Group holds with the DLA. The IDV enables the DLA to issue delivery orders for...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The order is for the supply of Xolair 150 mg/mL syringes, with a potential value of $37,137.60 and a completion date of January 12, 2024. The delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group Inc. with DLA, valued up to $5 million through December 2025, to provide a variety of pharmaceutical items...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, with a completion date of March 13, 2024 and a potential value of $6,189.60. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the...
- This is a delivery order awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The order is for XOLAIR 150 MG/ML SYRINGE, with a firm fixed price of $13,926.60 and a completion date of February 20, 2024. The order is placed under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the Defense Logistics Agency, a single-award vehicle valued up to $4,999,999 through 2025 that enables the DLA to issue...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, number SPE2DB24FZB70, to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide XOLAIR 150 MG/ML SYRINGEML. The $18,568.80 order has an ultimate completion date of April 16, 2024. This delivery order is part of a larger indefinite delivery contract, number SPE2DB22D9143, that DMS Pharmaceutical Group holds with DLA, valued at up to $4,999,999 through the end of 2025. The IDC enables DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of XOLAIR 150 mg/mL syringes. The firm-fixed-price contract has a ceiling value of $4,642.20 and an ultimate completion date of April 13, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue...